BURKITT'S LYMPHOMA STAGE IV

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting BURKITT'S LYMPHOMA STAGE IV:

# Drug Count
0 AMLODIPINE BESYLATE 1
1 ARGATROBAN 1
2 AZATHIOPRINE 1
3 DIGOXIN 1
4 INFLIXIMAB 1
5 INTERFERON BETA-1A 1
6 LORAZEPAM 1
7 MESALAMINE 1
8 METHYLPREDNISOLONE 1
9 METOPROLOL 1
See all common drugs associated with BURKITT'S LYMPHOMA STAGE IV

BURKITT'S LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ARGATROBAN 1 0.0007
1 PHYTONADIONE 1 0.0001
2 MESALAMINE 1 0.0000
3 DIGOXIN 1 0.0000
4 AZATHIOPRINE 1 0.0000
5 METHYLPREDNISOLONE 1 0.0000
6 AMLODIPINE BESYLATE 1 0.0000
7 TACROLIMUS 1 0.0000
8 LORAZEPAM 1 0.0000
9 INTERFERON BETA-1A 1 0.0000
See all drugs enriched for association with BURKITT'S LYMPHOMA STAGE IV

BURKITT'S LYMPHOMA STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 1 0.0003
1 Vitamin K [EPC] 1 0.0001
2 Cardiac Glycoside [EPC] 1 0.0000
3 Purine Antimetabolite [EPC] 1 0.0000
4 Aminosalicylate [EPC] 1 0.0000
5 Interferon beta [EPC] 1 0.0000
6 Benzodiazepine [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with BURKITT'S LYMPHOMA STAGE IV